Compounds > 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline)
Page last updated: 2024-08-26

6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Local Neoplasm Recurrence

6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) has been researched along with Local Neoplasm Recurrence in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schratter-Sehn, AU; Szepesi, T1

Trials

1 trial(s) available for 6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline) and Local Neoplasm Recurrence

ArticleYear
[First clinical experiences with the radiosensitizer MTDQ in advanced primary and recurrent tumors].
    Wiener klinische Wochenschrift, 1983, Aug-05, Volume: 95, Issue:15

    Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Combined Modality Therapy; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Quinolines

1983